Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma

被引：0
|
作者：
Berretta, M. [1 ]
Di Francia, R. [2 ,3 ]
Tirelli, U. [1 ]
机构：
[1] NCI, Dept Med Oncol, Aviano, PN, Italy
[2] Fdn G Pascale IRCCS, NCI, Hematol Oncol & Stem Cell Transplantat Unit, Naples, Italy
[3] Italian Assoc Pharmacogen & Mol Diagnost, Naples, Italy
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2015年 / 19卷 / 14期
关键词：
HIV-INFECTED PATIENTS; LIVER-TRANSPLANTATION; POSITIVE PATIENTS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2521 / 2522
页数：2
相关论文
共 50 条
  • [1] Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma
    Kan, X.
    Jing, Y.
    Wan, Q. -Y.
    Pan, J. -C.
    Han, M.
    Yang, Y.
    Zhu, M.
    Wang, Q.
    Liu, K. -H
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (02) : 247 - 255
  • [2] Percutaneous Radiofrequency Ablation with Multiple Electrodes for Medium-Sized Hepatocellular Carcinomas
    Lee, Jung
    Lee, Jeong Min
    Yoon, Jung-Hwan
    Lee, Jae Young
    Kim, Se Hyung
    Lee, Jeong Eun
    Han, Joon Koo
    Choi, Byung Ihn
    KOREAN JOURNAL OF RADIOLOGY, 2012, 13 (01) : 34 - 43
  • [3] Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis
    Chu, Hee Ho
    Kim, Jin Hyoung
    Yoon, Hyun-Ki
    Ko, Heung-Kyu
    Gwon, Dong Il
    Kim, Pyo Nyun
    Sung, Kyu-Bo
    Ko, Gi-Young
    Kim, So Yeon
    Park, Seong Ho
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (10) : 1533 - 1543
  • [4] Advantage of sorafenib combined with radiofrequency ablation for treatment of hepatocellular carcinoma
    Tang, Zhe
    Kang, Muxing
    Zhang, Bo
    Chen, Jianke
    Fang, Heqing
    Ye, Qin
    Jiang, Biao
    Wu, Yulian
    TUMORI, 2017, 103 (03) : 286 - 291
  • [5] Combined Transarterial Chemoembolization and Percutaneous Radiofrequency Ablation: More Promising Evidence of Effectiveness in Treating Solitary, Medium-Sized Hepatocellular Carcinoma
    Shah, Ketan Y.
    Gaba, Ron C.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (10) : 1545 - 1548
  • [6] Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation
    Zhu, Kangshun
    Huang, Jingjun
    Lai, Lisha
    Huang, Wensou
    Cai, Mingyue
    Zhou, Jingwen
    Guo, Yongjian
    Chen, Junwei
    RADIOLOGY, 2018, 288 (01) : 300 - 307
  • [7] Percutaneous Radiofrequency Ablation With a Multiple-Electrode Switching System for Medium-Sized Hepatocellular Carcinomas
    Tan, Tunhua
    Li, Xuesong
    Wang, Qiang
    Li, Kun
    Ma, Kuansheng
    INTERNATIONAL SURGERY, 2021, 105 (1-3) : 489 - 496
  • [8] Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone
    Jin Hyoung Kim
    Hyung Jin Won
    Yong Moon Shin
    Sung Hee Kim
    Hyun-Ki Yoon
    Kyu-Bo Sung
    Pyo Nyun Kim
    Annals of Surgical Oncology, 2011, 18 : 1624 - 1629
  • [9] Percutaneous radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: assessment of palliative treatment
    Jaworski, Maciej
    Rowinski, Olgierd
    Cieszanowski, Andrzej
    Krawczyk, Marek
    Najnigier, Boguslaw
    WIDEOCHIRURGIA I INNE TECHNIKI MALOINWAZYJNE, 2009, 4 (02): : 59 - 66
  • [10] Medium-Sized (3.1-5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone
    Kim, Jin Hyoung
    Won, Hyung Jin
    Shin, Yong Moon
    Kim, Sung Hee
    Yoon, Hyun-Ki
    Sung, Kyu-Bo
    Kim, Pyo Nyun
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (06) : 1624 - 1629
12345